When patients show low GLP-1 persistence or discontinue their medications early, they dont achieve the weight loss needed to reduce their risk for cardiometabolic diseases, and payers face wasted spend and insufficient ROI
GLP-1RAs inhibit RGC apoptosis in glaucoma through GABAergic signaling, but their role in AMD, characterized by oxidative stress and choroidal neovascularization, needs further investigation ( The latest diabetic retinopathy preferred practice guidelines from the American Academy of Ophthalmology indicate that the rising use of GLP-1RAs may lead to quick glycemic control and severe hypoglycemia and has been reported to cause higher rates of retinopathy complications, especially in patients with early-stage DR ( 4.2 Delivery optimization Systemic administration of GLP-1RAs reduces their availability in the retina and can lead to off-target effects, particularly gastrointestinal issues
Sarcoma 2014 , 498682 (2014)
Twenty-eight patients were in cancer stage I and 32 patients were in cancer stage II, and more than two-thirds of patients had poorly differentiated HCC
Sermorelin Before & After Timeline: Week-by-Week Results & What to Expect Contents show Sermorelin Before & After Timeline: What to Expect Week by Week Patients beginning Sermorelin therapy often ask when they may notice changes and what improvements they should realistically expect over time